Skip to content

Clinical trials

Phase 1 Schizophrenia trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 1 Status: Unknown status Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20161
20182
20202
20211
20226
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu Hansoh Pharmaceutical Co., Ltd.2
Abarbanel Mental Health Center1
Brian Miller1
Jiangsu Kanion Pharmaceutical Co., Ltd1
Jiangsu Nhwa Pharmaceutical Co., Ltd.1
King's College London1
North Suffolk Mental Health Association1
Pakistan Institute of Living and Learning1
Shanghai Mental Health Center1
Sir Run Run Shaw Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia16
Psychotic Disorders3
Anxiety Disorders1
Cognitive Dysfunction1
Disease1
Inflammation1
Major Depressive Disorder1
Mental Disorders1
Neurobehavioral Manifestations1
Schizophrenia, Treatment-Resistant1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.